![Are drugs really driving the latest drop in lung cancer mortality? Looks like treatment is playing a role, experts say](https://cdn.cancerletter.com/media/2020/02/25191942/lung-4x3-1.jpg)
![Are drugs really driving the latest drop in lung cancer mortality? Looks like treatment is playing a role, experts say](https://cdn.cancerletter.com/media/2020/02/25191942/lung-4x3-1.jpg)
Cover Story
On Jan. 8, the American Cancer Society published its annual estimates of new cancer cases and deaths, declaring that the latest data—from 2016 to 2017—show the “largest ever single-year drop in overall cancer mortality of 2.2%.”
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for Feb. 2020
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Lei Zheng named executive director of Mays Cancer Center
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center